BX-1

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameBX-1

Drug Alias Name11beta-dehydrogenase inhibitor (Bionetworks)BX-1

ClassificationNatural product/ExtractSmall molecules

Mechanisms of Action11-beta-hydroxysteroid dehydrogenase inhibitors

Targets11-beta-hydroxysteroid dehydrogenase

Therapy Area/IndicationsPeriodontitisArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBionetworks GmbH

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBionetworks GmbH

Active IndicationsN/A

Inactive IndicationsPeriodontitisArthritis, Rheumatoid

ATC CodeN/A